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Sedentary Behavior and Physical Activity in Youth With
Recent Onset of Type 2 Diabetes
WHAT’S KNOWN ON THIS SUBJECT: The rise in type 2 diabetes in
youth is a major public health concern thought to be partially due
to decreasing activity levels and increasing obesity. The role of
sedentary time as a possible contributor also needs to be
examined.
WHAT THIS STUDY ADDS: Measured objectively, obese youth, with
or without type 2 diabetes, spend little time in moderate to
vigorous physical activity. Those with type 2 diabetes, however,
were significantly more sedentary than their obese counterparts,
identifying an important area for future intervention efforts.
abstract
OBJECTIVE: With the rise of type 2 diabetes in youth, it is critical to
investigate factors such as physical activity (PA) and time spent
sedentary that may be contributing to this public health problem.
This article describes PA and sedentary time in a large cohort of
youth with type 2 diabetes and compares these levels with other
large-scale investigations.
METHODS: The Treatment Options for Type 2 Diabetes in Adolescents
and Youth (TODAY) trial is a study in 699 youth, recruited from 15 US
clinical centers, aged 10 to 17 years with ,2 years of type 2 diabetes
and a BMI $85th percentile.
RESULTS: In comparison with the subset of the NHANES cohort who
were obese (BMI $95th percentile), TODAY youth spent significantly
more time being sedentary (difference averaging 56 minutes per day;
P , .001) as assessed by accelerometry. Although moderate to vig-
orous activity levels in both obese cohorts for all age groups were
exceptionally low, younger TODAY boys were still significantly less
active than similarly aged NHANES youth. Comparisons between the
TODAY girls and other investigations suggest that the TODAY girls also
had relatively lower PA and fitness levels.
CONCLUSIONS: Adolescents with type 2 diabetes from the large TODAY
cohort appear to be less physically active and tend to spend more time
being sedentary than similarly aged youth without diabetes identified
from other large national investigations. Treatment efforts in adoles-
cents with type 2 diabetes should include decreasing sitting along with
efforts to increase PA levels. Pediatrics 2013;131:e850–e856
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Obesity in youth is a critical public
health problem, with estimates for
the number of youth 10 to 17 years of
age who are overweight or obese
approaching 30%.1 This alarming prev-
alence of obesity is thought to be driving
the increasing rates of type 2 diabetes in
youth.2
One of the factors implicated in this
epidemic of both obesity and type 2 di-
abetesinyouth isphysical inactivity. Inan
investigation involving a representative
multiracial sample of US adolescents
aged 12 to 19 years without diabetes,
physical activity (PA) andcardiovascular
fitness were found to be positively as-
sociated with insulin sensitivity in boys
and, to a lesserextent, in girls.3 However,
whether youth with type 2 diabetes are
less active and spend more time sitting
than do nondiabetic youth, particularly
obese nondiabetic youth, has not been
examined.
A National Institute of Diabetes and Di-
gestive and Kidney Diseases–funded
randomized clinical trial was conducted
to examine various treatment therapies
for youth with type 2 diabetes. The
Treatment Options for Type 2 Diabetes in
Adolescents and Youth (TODAY) study
represents the largest ethnically and
geographically diverse group of pediat-
ric patients with type 2 diabetes ever
assembled. This article describes the PA/
inactivity levels, determined both objec-
tively with accelerometry and sub-
jectively by questionnaire, along with
cardiovascular fitness levels in this co-
hort. It is hypothesized that these youth
with type 2 diabetes spend more time
sitting and less time in moderate to vig-
orous PA than do similarly aged obese
youth from a national cohort and other
large-scale investigations of adolescents.
METHODS
The TODAY trial was a randomized,
double-blind, parallel-group clinical trial
designed toevaluate the relative efficacy
and safety of 3 treatments for type 2
diabetes in youth: metformin alone,
metformin plus rosiglitazone, and met-
formin plus an intensive lifestyle pro-
gram.4 The primary objective of the trial
was to compare the 3 treatment arms
on time to treatment failure, defined as
loss of glycemic control.
Participants were recruited from 15
clinical centers aspreviously described4
(see the study group listing in the Sup-
plemental Information). Enrollment
ended in February 2009 with 699 youth
enlisted. Entry criteria for participants
were as follows: aged 10 to 17 years,
with,2 years of type 2 diabetes; a BMI
$85th percentile at time of diagnosis or
at screening; availability and agreement
of an adult caregiver to support partici-
pation; negative for pancreatic autoim-
munity (both glutamic acid decarboxylase
and anti-tyrosine phosphatase anti-
bodies); and fasting C-peptide .0.6
ng/mL. Participants with hemoglobin-
opathies were excluded.
Before randomization, a run-in period
was performed to ensure that partic-
ipants were able to tolerate therapy
with metformin, accomplish mastery of
a standard diabetes education curricu-
lum, and demonstrate the ability to ad-
here to study requirements for pill
taking and visit attendance.4 The youth
who successfully completed the 2- to 6-
month run-in period were found to de-
crease their weight by a mean of 0.68
kg compared with a 0.71 kg weight
gain in those who failed the run-in
period.
The youth who successfully completed
the run-in period were randomly
assigned into themain clinical trial and
completed baseline measures.5 This
article describes the PA and cardiore-
spiratory fitness levels of the youth
who mastered the run-in period and
entered the formal trial. During the
baseline visit of the clinical trial, an
objective and a subjective measure of
PA were performed along with mea-
surement of cardiorespiratory fitness.
Anthropometric Measures
All anthropometric measures were
conducted with youth wearing light-
weight clothing and without shoes by
trained and certified research staff.
Height was measured to the nearest 0.1
cm, and weight was measured to the
nearest 0.1 kg. BMI was calculated as
kilograms/meters squared, and BMI z
score was derived from the gender- and
age-specific standards published by the
National Center for Health Statistics.6
Accelerometry
ObjectivePAdatawerecollectedbyusing
the ActiGraph AM7164 accelerometer
(ActiGraph, Pensacola, FL), which was
worn at thewaist andmeasured vertical
acceleration. Previous studies have re-
vealed that the ActiGraph accelerometer
is an accuratemeasure of PA in children
and adolescents.7
Participants receivedanaccelerometer
before their clinic visit and wore the
accelerometer for a period of 7 days.
Participants were asked to record in
a diary the time at which they put on the
monitors in the morning and the time
they tookoff themonitorsatnight. At the
end of the 7-day period, the participant
returned the accelerometer and diary
at his or her clinic visit. Data from the
accelerometer were downloaded, pro-
cessed, and screened for wear time by
using a modified version of previously
reported methods (http://riskfactor.
cancer.gov/tools/nhanes). Average to-
tal activity counts per day were calcu-
lated by using summed daily counts
detected over wear periods. Time in
minutes spent in different activity in-
tensities was calculated by using age-
specific formulas for count cutoffs
(metabolic equivalents [METs] = 2.757 +
[0.00153 cpm] – [0.08963 age (years)]
– [0.000038 3 cpm 3 age]) corre-
sponding to sedentary, light (1–3.99
METs), moderate (4–6.99 METs), and vig-
orous intensity ($7 METs). (A MET is an
estimate of relative intensity such that 1
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MET represents the energy expenditure
for an individual at rest, whereas a 10-
MET activity requires 10 times that
amount.) These intensity levels were
derived from a published age-specific
energy expenditure prediction equa-
tion.8 To be included in these analyses,
participants must have had acceler-
ometer data that included 10 hours of
wear time on$3 valid days. Non–wear
time was defined as intervals of $60
consecutive minutes of zero counts with
allowance for up to 2 minutes of
observations of 1 to 100 cpm. Wear time
was determined by subtracting non–
wear time from the total observation
time for that day. Time spent in seden-
tary behavior was defined as the
amount of time accumulated in counts
that were ,100 cpm.
NHANES Accelerometry
During NHANES 2005–2006, accelero-
metry measures were collected from
a nationally representative sample of US
civilian noninstitutionalized adults and
youth (N = 7086) by using the same ac-
celerometer model (ActiGraph) and
methodology as was used in TODAY.9
NHANES participants were asked to
wear the device during their waking
hours and to remove the monitor for
water-related activities.10 For the data
presented here, only participants aged
10 to 17 years old with accelerometer
data that included $10 hours of moni-
tor wear time on $3 valid days were
included. PA variables for either TODAY
or NHANES participants with 3 days of
accelerometer data were not signifi-
cantly different than those for partic-
ipantswith$5 days. Pregnant girls and/
or children with missing BMI in-
formation were also excluded. The
weighted characteristics for this sample
were as follows: 51.5% boys, 62.4% non-
Hispanic white, 14.6% non-Hispanic
black, 15.5% Hispanic, 7.5% other race/
ethnicity, and 16.3% obese. For the cur-
rent comparison, only obese NHANES
youth (BMI $95th percentile) were
included (n = 312; 177 youth aged 10–14
years and 135 youth aged 15–17 years).
Physical Work Capacity
Cardiorespiratory fitness was assessed
by using a submaximal test that deter-
mines the physical work capacity (PWC)
of an individual by predicting the work-
load (kg*m) at a heart rate of 170 beats
per minute with a Monark 818E cycle
ergometer (Quinton Monark, Seattle,
WA).11 The heart rate recorded from the
last 5 seconds of each stage was used to
extrapolate a PWC at a heart rate of 170
beats per minute (PWC-170). A best-fit
line was used to approximate the
workload of the bike at a heart rate of
170 beats per minute, resulting in an
estimate of the PWC-170 expressed in
kilogram*meters per minute. The raw
measurement of PWC was divided by the
participant’s weight in kilograms to
provide a weight-adjusted estimate.
Participantswere required to complete
the test within 24 hours of when their
accelerometer data were downloaded,
but not within 48 hours of an oral glu-
cose tolerance test, because the test
was to be performed nonfasting. Par-
ticipants who weighed $350 lb were
excluded from the PWC-170 assess-
ment due to bike weight limits. In ad-
dition, the test was discontinued for
individuals who were unable to main-
tain a minimal speed during the warm-
up period. Individuals who failed to
complete the test due to leg pain or
lack of motivation or whose heart rate
exceeded 170 beats per minute during
the initial stage were also excluded.
Trial of Activity for Adolescent Girls
and Lifestyle Education for Activity
Program PWC-170 Protocol
The Trial of Activity for Adolescent Girls
(TAAG)wasarandomizedcontrolled trial
examining the effect of an intervention
to reduce the decline of PA levels in
middle school–aged girls12 and was
composed of 45% non-Hispanic white,
21% Hispanic, and 21% non-Hispanic
black girls. The Lifestyle Education for
Activity Program (LEAP) was an activity
intervention that began in eighth-grade
girls who were then followed through to
high school13 and was composed of 51%
non-Hispanic white and 49% non-
Hispanic black girls. Both TAAG and
LEAP used the PWC-170 to determine
cardiorespiratory fitness13,14 with a
similar protocol as that used in TODAY.
Both TAAG and LEAP conducted the test
with 2-minute stages; however, neither
study provides information regarding
exclusion criteria on the basis of par-
ticipant weight. In addition, TAAG im-
puted values for participants who
maintained proper cadence, but who
completed only 2 stages.14 Assessments
in TAAG and LEAP were conducted in girls
aged 13 to 14 years.
Comparisons of baseline fitness and
activity levels (3-day physical activity
recall [3DPAR] below) between the
TODAY girls and those from TAAG and
LEAP were performed, although there
were too few obese girls in the later 2




Subjective PA data were measured by
using the 3DPAR, which is a self-
administered questionnaire of PA for
the previous 3 days.15 The 3DPAR was
administered during the clinic visit, after
the participant’s use of the acceler-
ometer, and asked about the recall of
activity over the time period that co-
incided with the final 3 days of acceler-
ometer monitoring. Trained interviewers
guided the process of completing the
questionnaire.
On the basis of a list of leisure, occu-
pation, and daily living activities, par-
ticipantswere asked to record themain
activity that they participated in during
each30-minute time incrementover the
past3days. Theywerealso instructed to
e852 KRISKA et al
estimate the intensity level of the ac-
tivity (light, moderate, hard, or very
hard). Intensity values (METs) were
assigned to each of the activities and
their 4 intensity levels listed on the
questionnaire.16 PA from the 3DPAR was
analyzed in terms of total hours of PA
and total dailyMET hours (the total being
the sum of the various intensity levels).
Statistical Methods
All statistical analyses were conducted
in SAS versions 9.1 and 9.2 (SAS In-
stitute, Cary, NC). x2 tests were used to
compare the percentages of gender,
age, race, and BMI categories among
all study participants with those indi-
viduals who had complete data for the
3DPAR, the accelerometer, and/or the
PWC-170 fitness test. Means, SDs, and
SEs for TODAY were calculated by gen-
der, age group (10–14 and 15–17
years), and race/ethnic group. Means
and SEs for NHANES used weighting
procedures, on the basis of the sam-
pling strategy, to ensure that the
results were representative of the US
population. Independent sample t tests
were used to test the differences be-
tween groups, and t tests for compar-
isons between NHANES and TODAY trial
participants used the weighted SEs for
the NHANES data.
RESULTS
A total of 699 adolescents participated
in the TODAY trial. The number of youth
who successfully completed each PA/
fitness measure at baseline was 672
for the 3DPAR, 242 for accelerometry,
and 527 for the PWC-170. The relatively
smaller number of youth (34% of the
entire cohort)withusableaccelerometry
data was due to both a computer error
that accidentally erased the first 29% of
the accelerometry records collected and
the fact that 37% of the youth either re-
fused to wear the monitor or had in-
complete records (less than $3 valid
days of accelerometer). Those adoles-
cents who completed all 3 of these
activity/fitness measures were not sta-
tistically different from thosewhodid not
complete the measures in regard to age,
gender, race/ethnicity, or BMI (data not
shown).
The study population was composed of
17.8% non-Hispanic white, 45% His-
panic, and 29.8% non-Hispanic black
youthpredominantly from families of low
educational level and annual household
income (Table 1). For all age and gender
groups, the rates of obesity were high.
In comparisons between both gender
and age groups, the BMI z scores were
similar.
Accelerometry
The mean minutes per day spent in
moderate to vigorous activity, light ac-
tivity, total activity (moderate/vigorous
plus light), and sedentary time as
TABLE 1 Baseline Descriptive Statistics for the TODAY Study Cohort
P
Boys Girls By Age Among By Gender Among
10–14 y 15–18 y 10–14 y 15–18 y Boys Girls 10–14 y 15–18 y
Anthropomorphic measures
n 114 133 279 173
Weight, kg 95.7 6 27.8 112.6 6 25.8 84.9 6 19.8 100.1 6 22.6 ,.0001 ,.0001 ,.0001 ,.0001
Height, cm 166.5 6 10.6 174.4 6 7.4 160.9 6 7.4 163.5 6 7.4 ,.0001 ,.0001 ,.0001 ,.0001
BMI, kg/m2 34.1 6 8.1 37.0 6 8.0 32.8 6 6.5 37.3 6 7.8 ,.01 ,.0001 .10 .70
BMI z score 2.3 6 0.5 2.4 6 0.5 2.2 6 0.4 2.1 6 0.4 .07 .45 .04 ,.0001
Accelerometry
n 45 50 96 51
Sedentary, min/d 495.3 6 144.4 526.6 6 143.4 479.0 6 141.0 546.5 6 143.0 .29 ,.01 .53 .49
Light PA, min/d 338.3 6 90.9 330.1 6 71.5 348.6 6 75.4 344.9 6 101.1 .63 .80 .48 .40
Moderate–vigorous PA, min/d 35.0 6 26.0 26.3 6 24.1 26.6 6 18.3 8.2 6 8.9 .09 ,.0001 .03 ,.0001
Total activity,a min/d 373.3 6 99.5 356.4 6 76.9 375.2 6 80.4 353.1 6 104.2 .35 .16 .91 .86
Physical fitness
n 81 102 209 135
PWC-170, kg.m × min21 799.9 6 261.1 909.4 6 287.5 628.7 6 201.7 649.2 6 196.0 ,.01 .35 ,.0001 ,.0001
PWC-170/kgb 8.8 6 2.8 8.6 6 3.2 7.61 6 2.7 6.7 6 2.0 .70 ,.01 ,.001 ,.0001
3DPAR
n 108 131 271 162
Sedentary, h/d 6.0 6 2.8 5.9 6 2.9 5.6 6 2.8 5.7 6 3.0 .91 .94 .29 .44
Light, h/d 5.5 6 2.2 6.5 6 2.6 6.3 6 2.3 7.1 6 2.3 ,.01 ,.001 ,.01 .04
Moderate–vigorous, h/d 1.9 6 1.8 1.3 6 1.4 1.4 6 1.3 1.1 6 1.4 ,.01 .02 ,.01 .12
Total activity,a MET-h/d 64.3 6 18.9 59.9 6 14.5 59.9 6 13.1 58.3 6 12.3 .04 .22 .01 .33
Data are presented as means6 SD unless otherwise indicated. P values from t-tests represent age group comparisons within each gender, and gender comparisons within each age group.
n = 7 participants (or 1% of the TODAY baseline cohort) turned 18 years old between recruitment and baseline data collection.
a Total = light + moderate–vigorous PA.
b PWC adjusted for weight (in kg).
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determined by accelerometry are pre-
sented in Fig 1 for both TODAY youth and
the obese NHANES youth (BMI $95th
percentile). These age-adjusted data
are presented by gender and age
group (10–14 and 15–17 years of age).
The obese NHANES 10- to 14-year-old
boys were more active than similarly
aged TODAY boys for both total (P, .05)
and light (P = .06) PA. The NHANES
younger boys had higher moderate to
vigorous activity levels than the TODAY
boys (P, .01), although the mean time
spent in moderate to vigorous activity
for all age/gender groups was excep-
tionally low.
In comparisons of these 2 groups of
obese youth, the most striking finding
wasthehigheramountofsedentary time,
averaging 56minutes per day (P, .001),
spent in the TODAY youth relative to the
obese NHANES youth. Stratifying by gen-
der, these results reached statistical
significance in boys but not in girls.
PWC-170 Bike Test
Comparisons for baseline PWC-170
adjusted for weight (kg) between the
TODAY girls and those girls who par-
ticipated in TAAG14 and LEAP13 indicate
that the girls in TODAY had lower car-
diorespiratory fitness. The baseline
weight-adjusted PWC of girls in LEAP
and TAAG (aged 13–14 years) seemed
to be similar to mean values of 11.66
3.5 and 11.68 6 3.57, respectively.
However, the 13- to 14-year-old girls in
TODAY had a substantially lower mean
value (7.49 6 2.49). Similar findings
were noted for non–weight-adjusted
values (not shown here).
3DPAR
In comparison with other studies, girls in
TODAYhad lower reportedPA levels on the
basis of the 3DPAR. Specifically, girls in
TAAG reported a mean of 68 MET-hours/
day for sixth graders and 67 MET-hours/
day for eighth graders17 compared with
the TODAY girls who reported ∼58 to 60
MET-hours/day for both age groups.
DISCUSSION
The TODAY study population is one of the
largest cohorts of ethnically and geo-
graphically diverse youth with type 2
diabetes ever gathered. This current
effort suggests that the cohort tended
to be less active, less physically fit, and
FIGURE 1
A comparison of mean (SE) minutes of PA and sedentary behavior per day recorded by using accelerometry in girls and boys from the TODAY Trial at baseline
compared with NHANES 2005–2006 obese (BMI$95th percentile) youth. Statistical significance for between-group differences is based on means and SE of
the means for NHANES and TODAY: *P , .10, **P , .05, ***P , .01. n = 7 participants (or 1% of the TODAY baseline cohort) turned 18 years old between
recruitment and baseline data collection.
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more sedentary when compared with
similarly aged youth without diabetes
from other large-scale investigations.
Cross-sectional examination of PA lev-
els in the TODAY youth with type 2 di-
abetes compared with similarly aged
obese youth from the NHANES data set
revealed that the levels of moderate to
vigorous activity performed per day in
both obese cohorts for all age groups
were exceptionally low and that the
younger TODAY boys were even less
active than similarly aged NHANES
youth. Most consistently, TODAY youth,
as a whole, spent significantly more
time (close to an hour extra per day)
being sedentary than the obeseNHANES
youth, underscoring the need for ac-
tivity intervention at both ends of the
activity spectrum. This difference in
sedentary time could not be explained
by methodologic issues such as sea-
sonality (as both studies recruited
over all seasons) or wear time. Future
lifestyle interventions should target
the amount of time spent sitting rather
than focusing exclusively on increasing
the amount of moderate to vigorous
activity performed per day as both
appear to be a problem in this obese
diabetic cohort and both affect energy
expenditure.
In comparisons with other large-scale
investigations in girls, TODAY girls
appeared to have a relatively lower
cardiorespiratoryfitness than similarly
aged girlswho participated in TAAG and
LEAP.13,14 Also, girls in TODAY reported
lower PA levels on the basis of the
3DPAR than did similarly aged girls
from TAAG.17 These findings are con-
sistent with results from the SEARCH
case-control study in which youth with
type 2 diabetes were less active than
nondiabetic controls or youth with type
1 diabetes.18
The current findings need to be con-
sidered in light of the fact that the TODAY
study participants were more obese
than those in the comparison studies
such as NHANES. The subset of obese
youth (BMI $95th percentile) partici-
pating in NHANES had an average BMI
of 29.9 for boys and 30.9 for girls,
whereas similarly aged TODAY boys and
girls had an average BMI of 34.6 and
34.3, respectively. The fact that this
subgroup of youth with type 2 diabetes
was more obese than the most obese
5% of the NHANES population is not
surprising given the fact that obesity
and type 2 diabetes are extremely
coupled. This coupling of obesity and
diabetes makes the independent effect
of either condition relatively impossi-
ble to sort out.
It is important to note that youth who
participated inTODAYhad toundergoan
extensive run-in period before random
assignment. Those who successfully
completed the run-in phase had a de-
crease in weight relative to the youth
who failed the run-in phase. Therefore,
it is possible that the youth participat-
ing in the TODAY trial and included in the
current analyses were healthier, more
motivated, and/or more active relative
to youth with type 2 diabetes who failed
the run-in. The implication of this find-
ing is that the levels of activity and fit-
ness in the general population of type 2
diabetic adolescents may be even lower
than presented in this current effort.
This interpretation is consistent with
previous findings in adults that revealed
that individuals with prediabetes who
join a lifestyle intervention trial are
more active and likely more moti-
vated than those in the community
who are also eligible but choose not
to participate.19
CONCLUSIONS
In this national study involving the
largest cohort of youth with type 2
diabetes to date, the results indicate
that youth with type 2 diabetes have
poor activity habits, spending little
time in light and moderate to vigorous
intensity activities andhighamountsof
time insedentaryactivities. Inaddition,
the very low cardiovascular fitness of
these youth with type 2 diabetes has
important implications for their future
cardiovascular health as they enter
adulthood. Intervention efforts that
focus on increasing PA levels and de-
creasing time spent in sedentary be-
havior should be a priority for these
youth with type 2 diabetes.
ACKNOWLEDGMENTS
We acknowledge the youth and their
familieswho participated in this impor-
tant endeavor, the staff of TODAY for
their devotion and hard work, and Dr
Kristi Storti and Ms Bonny-Rockette
Wagner for their assistance in data
editing and validation.
This work was completed with funding
from National Institute of Diabetes and
Digestive and Kidney Diseases/National
Institutes of Health grant numbers U01-
DK61212, U01-DK61230, U01-DK61239,
U01-DK61242, and U01-DK61254; from
the National Center for Research Re-
sourcesGeneralClinicalResearchCenters
Program grant numbers M01-RR00036
(Washington University School of
Medicine), M01-RR00043-45 (Childrens
Hospital Los Angeles), M01-RR00069
(University of Colorado Denver), M01-
RR00084 (Children's Hospital of Pitts-
burgh), M01-RR01066 (Massachusetts
General Hospital), M01-RR00125 (Yale
University), and M01-RR14467 (Univer-
sity of Oklahoma Health Sciences Cen-
ter); and from the NCRR Clinical and
Translational Science Awards grant
numbers UL1-RR024134 (Children'sHos-
pital of Philadelphia), UL1-RR024139 (Yale
University), UL1-RR024153 (Children’s
Hospital of Pittsburgh), UL1-RR024989
(Case Western Reserve University),
UL1-RR024992 (Washington Univer-
sity), UL1-RR025758 (Massachusetts
General Hospital), and UL1-RR025780
(University of Colorado Denver). The
TODAY Study Group thanks the fol-
lowing companies for donations in
ARTICLE
PEDIATRICS Volume 131, Number 3, March 2013 e855
support of the study’s efforts:
Becton, Dickinson and Company;
Bristol-Myers Squibb; Eli Lilly and
Company; GlaxoSmithKline; LifeScan,
Inc.; Pfizer; Sanofi-aventis. We also
gratefully acknowledge the partici-
pation and guidance of the American
Indian partners associated with the
clinical center located at the Univer-
sity of Oklahoma Health Sciences
Center, including members of the Ab-
sentee Shawnee Tribe, Cherokee Na-
tion, Chickasaw Nation, Choctaw
Nation of Oklahoma, and Oklahoma
City Area Indian Health Service; the
opinions expressed in this paper
are those of the authors and do not
necessarily reflect the views of the
respective Tribal and Indian Health
Service Institution Review Boards
or their members.
REFERENCES
1. Data Resource Center. National survey of
children’s health. Available at: www.nschdata.
org/Content/Default.aspx. Accessed November
9, 2010
2. Liese AD, D’Agostino RB Jr, Hamman RF,
et al; SEARCH for Diabetes in Youth Study
Group. The burden of diabetes mellitus
among US youth: prevalence estimates
from the SEARCH for Diabetes in Youth
Study. Pediatrics. 2006;118(4):1510–1518
3. Imperatore G, Cheng YJ, Williams DE, Fulton
J, Gregg EW. Physical activity, cardiovascu-
lar fitness, and insulin sensitivity among U.
S. adolescents: the National Health and
Nutrition Examination Survey, 1999-2002.
Diabetes Care. 2006;29(7):1567–1572
4. Zeitler P, Epstein L, Grey M, et al; TODAY Study
Group. Treatment options for type 2 diabetes
in adolescents and youth: a study of the
comparative efficacy of metformin alone or
in combination with rosiglitazone or lifestyle
intervention in adolescents with type 2 di-
abetes. Pediatr Diabetes. 2007;8(2):74–87
5. Copeland KC, Zeitler P, Geffner M, et al; TO-
DAY Study Group. Characteristics of adoles-
cents and youth with recent-onset type 2
diabetes: the TODAY cohort at baseline. J
Clin Endocrinol Metab. 2011;96(1):159–167
6. Kuczmarski RJ, Ogden CL, Guo SS, et al.
2000 CDC Growth Charts for the United
States: methods and development. Vital
Health Stat. 2002;11(246):1–190
7. Trost SG, Ward DS, Moorehead SM, Watson
PD, Riner W, Burke JR. Validity of the
computer science and applications (CSA)
activity monitor in children. Med Sci Sports
Exerc. 1998;30(4):629–633
8. Trost SG, Pate RR, Sallis JF, et al. Age and
gender differences in objectively measured
physical activity in youth. Med Sci Sports
Exerc. 2002;34(2):350–355
9. Troiano RP, Berrigan D, Dodd KW, Mâsse LC,
Tilert T, McDowell M. Physical activity in the
United States measured by accelerometer.
Med Sci Sports Exerc. 2008;40(1):181–188
10. Centers for Disease Control and Prevention.
National Health and Nutrition Examination




11. Baumgartner TA. Measurement for Evalua-
tion in Physical Education and Exercise Sci-
ence. 8th ed. Boston, MA: McGraw-Hill; 2007
12. Stevens J, Murray DM, Catellier DJ, et al.
Design of the Trial of Activity in Adolescent
Girls (TAAG). Contemp Clin Trials. 2005;26
(2):223–233
13. Pfeiffer KA, Dowda M, Dishman RK, Sirard JR,
Pate RR. Physical fitness and performance.
Cardiorespiratory fitness in girls—change
from middle to high school. Med Sci Sports
Exerc. 2007;39(12):2234–2241
14. Lohman TG, Ring K, Pfeiffer K, et al. Rela-
tionships among fitness, body composition,
and physical activity. Med Sci Sports Exerc.
2008;40(6):1163–1170
15. McMurray RG, Ring KB, Treuth MS, et al.
Comparison of two approaches to struc-
tured physical activity surveys for adoles-
cents. Med Sci Sports Exerc. 2004;36(12):
2135–2143
16. Ainsworth BE, Haskell WL, Whitt MC, et al.
Compendium of physical activities: an up-
date of activity codes and MET intensities.
Med Sci Sports Exerc. 2000;32(suppl 9):
S498–S504
17. Pate RR, Stevens J, Webber LS, et al. Age-
related change in physical activity in adoles-
cent girls. J Adolesc Health. 2009;44(3):275–282
18. Lobelo F, Liese AD, Liu J, et al. Physical activity
and electronic media use in the SEARCH for
diabetes in youth case-control study. Pediat-
rics. 2010;125(6). Available at: www.pediatrics.
org/cgi/content/full/125/6/e1364
19. Kriska AM, Edelstein SL, Hamman RF, et al.
Physical activity in individuals at risk for
diabetes: Diabetes Prevention Program.
Med Sci Sports Exerc. 2006;38(5):826–832
(Continued from first page)
This trial has been registered at www.clinicaltrials.gov (identifier NCT00081328).
www.pediatrics.org/cgi/doi/10.1542/peds.2012-0620
doi:10.1542/peds.2012-0620
Accepted for publication Nov 5, 2012
Address correspondence to Laure El ghormli, MS, The Biostatistics Center, George Washington University, 6110 Executive Blvd, Suite 750, Rockville, MD 20852. E-mail:
elghorml@bsc.gwu.edu
PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).
Copyright © 2013 by the American Academy of Pediatrics
FINANCIAL DISCLOSURE: Dr Copeland is on the National Advisory Committee and a consultant with Honoraria to Novo Nordisk and Daiichi Sankyo Inc; Dr Kelsey is
an investigator for type 2 diabetes sponsored by Daichii Sankyo, Bristol-Myers Squibb, and Merck; Ms Milaszewski is a consultant for Medtronic insulin pumps; the
other authors have indicated they have no financial relationships relevant to this article to disclose.
FUNDING: This work was completed with funding from the National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health (grant U01-
DK61212, U01-DK61230, U01-DK61239, U01-DK61242, and U01-DK61254). Funded by the National Institutes of Health (NIH).
e856 KRISKA et al
